Valneva plunges after Europe slashes Covid-19 vaccine order
After the EU significantly reduced the size of a supply agreement for Valneva’s alternative Covid-19 vaccine, investors have punished the French pharmaceutical firm on the stock exchange.
by tim loh, bloomberg
Valneva SE fell as much as 15% after the European Union slashed its order of the French company’s Covid-19 vaccine.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Regulators agree on Covid-19 vaccination adaptation plan
For subscribers
Novavax's Covid-19 vaccine backed by CDC experts
For subscribers
.jpg)
.jpg&w=384&q=75)
